Assessment of bias in outcomes reported in trials on pneumonia: a systematic review

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
T AvniMical Paul

Abstract

Subjective outcomes may exaggerate intervention effects compared to objectively measured outcomes. We compared effect estimates for clinical failure and all-cause mortality clinical trials of antibiotic treatment for pneumonia. A systematic review of randomized controlled trials assessing adults with pneumonia, comparing different antibiotics, published between 2005 and 2012 was undertaken. We compared the intervention to the control arm. The all-cause mortality in the intention-to-treat population and clinical failure as defined by the study investigators for the primary analyzed population were the primary outcomes examined. Risk ratios (RRs) with 95 % confidence intervals (CIs) were pooled, using a fixed effect model. Meta-regression was used to examine the impact of clinical failure on the mortality effect size. Thirty-six trials were included, of which 30 were industry-sponsored and 30 were non-inferiority trials. There was no difference between the effect on mortality for intervention versus control (RR 1.02, 95 % CI 0.91-1.16) and clinical failure (RR 1.01, 95 % CI 0.93-1.10), without significant heterogeneity in both analyses. In double-blind trials with adequate sequence generation and concealment, there was a signific...Continue Reading

References

Feb 1, 1995·JAMA : the Journal of the American Medical Association·K F SchulzD G Altman
Jun 8, 2002·JAMA : the Journal of the American Medical Association·Ethan M BalkJoseph Lau
Jun 10, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H PortierP Zuck
Nov 17, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tobias WelteUNKNOWN MOXIRAPID Study Group
Dec 3, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Antonio AnzuetoUNKNOWN Community-Acquired Pneumonia Recovery in the Elderly Study Group
Jan 31, 2006·Medical Education·K D BlakeS Wakefield
Jan 31, 2006·American Journal of Epidemiology·Lise Lotte Gluud
Oct 7, 2006·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S V YakovlevM J DiNubile
Mar 3, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M TammI M Hoepelman
May 12, 2007·Journal of the American Geriatrics Society·Joseph A PaladinoJerome J Schentag
Jan 31, 2008·Infection·S R OttUNKNOWN German Lung Abscess Study Group
Apr 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Antoni TorresUNKNOWN MOTIV (MOxifloxacin Treatment IV) Study Group
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter E PertelJeff Alder
Nov 18, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brad SpellbergDavid N Gilbert
Nov 18, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M SingerS Gitterman
Nov 20, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brad SpellbergUNKNOWN Infectious Diseases Society of America
Mar 24, 2009·Journal of Chemotherapy·N DartoisUNKNOWN Tigecycline 313 Study Group
Sep 11, 2009·BMC Pulmonary Medicine·Cristina TanaseanuUNKNOWN 313 Study Group
Jul 28, 2010·Antimicrobial Agents and Chemotherapy·Dirkie J J van RensburgMing-Chu Hsu
Sep 18, 2010·Diagnostic Microbiology and Infectious Disease·Antonio T FreireUNKNOWN 311 Study Group
Jan 17, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Richard G WunderinkJean Chastre

❮ Previous
Next ❯

Citations

Feb 17, 2017·The Cochrane Database of Systematic Reviews·Andreas LundhLisa Bero

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.